A

ABL Bio Inc
KOSDAQ:298380

Watchlist Manager
ABL Bio Inc
KOSDAQ:298380
Watchlist
Price: 190 000 KRW -3.21% Market Closed
Market Cap: 10.5T KRW

Wall Street
Price Targets

Price Targets Summary
ABL Bio Inc

Wall Street analysts forecast ABL Bio Inc stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ABL Bio Inc is 151 980 KRW with a low forecast of 77 770 KRW and a high forecast of 220 500 KRW.

Lowest
Price Target
77 770 KRW
59% Downside
Average
Price Target
151 980 KRW
20% Downside
Highest
Price Target
220 500 KRW
16% Upside
ABL Bio Inc Competitors:
Price Targets
SKYE
Skye Bioscience Inc
715% Upside
ARX
Aroa Biosurgery Ltd
29% Upside
ELIC
Elicera Therapeutics AB
47% Upside
UTHR
United Therapeutics Corp
5% Upside
ENTA
Enanta Pharmaceuticals Inc
32% Upside
MNKD
MannKind Corp
56% Upside
87S
Roivant Sciences Ltd
15% Upside
BONEX
Bonesupport Holding AB
123% Upside

Revenue
Forecast

Revenue Estimate
ABL Bio Inc

For the last 7 years the compound annual growth rate for ABL Bio Inc's revenue is 141%. The projected CAGR for the next 3 years is 50%.

141%
Past Growth
50%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
ABL Bio Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
ABL Bio Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ABL Bio Inc's stock price target?
Price Target
151 980 KRW

According to Wall Street analysts, the average 1-year price target for ABL Bio Inc is 151 980 KRW with a low forecast of 77 770 KRW and a high forecast of 220 500 KRW.

What is ABL Bio Inc's Revenue forecast?
Projected CAGR
50%

For the last 7 years the compound annual growth rate for ABL Bio Inc's revenue is 141%. The projected CAGR for the next 3 years is 50%.

Back to Top